Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Tretinoin,Benzoyl Peroxide
Therapeutic Area : Dermatology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Sol-Gel Technologies Announces FDA Approval of TWYNEO®
Details : TWYNEO combines, for the first time, two of the most commonly used topical agents available for the treatment of acne into a single application. TWYNEO is the first FDA-approved fixed-dose combination of tretinoin and benzoyl peroxide.
Product Name : Twyneo
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
July 27, 2021
Lead Product(s) : Tretinoin,Benzoyl Peroxide
Therapeutic Area : Dermatology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable